Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2008 | 2 |
2009 | 1 |
2011 | 1 |
2014 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level.
Arch Dermatol. 2003 Feb;139(2):155-61. doi: 10.1001/archderm.139.2.155.
Arch Dermatol. 2003.
PMID: 12588221
Intratumoral Administration of a Novel Cytotoxic Formulation with Strong Tissue Dispersive Properties Regresses Tumor Growth and Elicits Systemic Adaptive Immunity in In Vivo Models.
Bender LH, Abbate F, Walters IB.
Bender LH, et al. Among authors: walters ib.
Int J Mol Sci. 2020 Jun 24;21(12):4493. doi: 10.3390/ijms21124493.
Int J Mol Sci. 2020.
PMID: 32599852
Free PMC article.
Item in Clipboard
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial.
Kudo M, Han G, Finn RS, Poon RT, Blanc JF, Yan L, Yang J, Lu L, Tak WY, Yu X, Lee JH, Lin SM, Wu C, Tanwandee T, Shao G, Walters IB, Dela Cruz C, Poulart V, Wang JH.
Kudo M, et al. Among authors: walters ib.
Hepatology. 2014 Nov;60(5):1697-707. doi: 10.1002/hep.27290. Epub 2014 Sep 29.
Hepatology. 2014.
PMID: 24996197
Clinical Trial.
Item in Clipboard
An observational, retrospective analysis of retreatment with bortezomib for multiple myeloma.
Conner TM, Doan QD, Walters IB, LeBlanc AL, Beveridge RA.
Conner TM, et al. Among authors: walters ib.
Clin Lymphoma Myeloma. 2008 Jun;8(3):140-5. doi: 10.3816/CLM.2008.n.016.
Clin Lymphoma Myeloma. 2008.
PMID: 18650176
Item in Clipboard
Retreatment with bortezomib alone or in combination for patients with multiple myeloma following an initial response to bortezomib.
Sood R, Carloss H, Kerr R, Lopez J, Lee M, Druck M, Walters IB, Noga SJ.
Sood R, et al. Among authors: walters ib.
Am J Hematol. 2009 Oct;84(10):657-60. doi: 10.1002/ajh.21517.
Am J Hematol. 2009.
PMID: 19731393
Free article.
Clinical Trial.
Item in Clipboard
Brivanib, a dual FGF/VEGF inhibitor, is active both first and second line against mouse pancreatic neuroendocrine tumors developing adaptive/evasive resistance to VEGF inhibition.
Allen E, Walters IB, Hanahan D.
Allen E, et al. Among authors: walters ib.
Clin Cancer Res. 2011 Aug 15;17(16):5299-310. doi: 10.1158/1078-0432.CCR-10-2847. Epub 2011 May 27.
Clin Cancer Res. 2011.
PMID: 21622725
Free PMC article.
Item in Clipboard
Utility of bortezomib retreatment in relapsed or refractory multiple myeloma patients: a multicenter case series.
Wolf J, Richardson PG, Schuster M, LeBlanc A, Walters IB, Battleman DS.
Wolf J, et al. Among authors: walters ib.
Clin Adv Hematol Oncol. 2008 Oct;6(10):755-60.
Clin Adv Hematol Oncol. 2008.
PMID: 18997666
Item in Clipboard
Cite
Cite